Shandong Xinhua Pharmaceutical Company Limited Class H(HK:0719)
HK$5.21-0.06 (-1.23%)
HK:0719
Shandong Xinhua Pharmaceutical Company Limited Class H financials statements
HK$5.21
At close:-0.06 (-1.23%)
Want to see HK:0719 full AI Analyst Report?
Shandong Xinhua Pharmaceutical Company Limited Class H (0719) Income Statement
2 Followers
Shandong Xinhua Pharmaceutical Company Limited Class H Income Statement
Last quarter (Q3 2026), Shandong Xinhua Pharmaceutical Company Limited Class H's total revenue was ¥1.70B, a decrease of 19.77% from the same quarter last year. In Q3, Shandong Xinhua Pharmaceutical Company Limited Class H's net income was ¥45.92M. See Shandong Xinhua Pharmaceutical Company Limited Class H’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ¥ 8.75B | ¥ 8.47B | ¥ 8.10B | ¥ 7.50B | ¥ 6.56B | |
| ¥ 1.64B | ¥ 2.04B | ¥ 2.32B | ¥ 2.04B | ¥ 1.77B | |
| ¥ 1.23B | ¥ 1.51B | ¥ 1.79B | ¥ 1.49B | ¥ 1.27B | |
| Depreciation and Amortization | ¥ 587.52M | ¥ 540.95M | ¥ 516.94M | ¥ 484.81M | ¥ 434.33M |
| ¥ 988.87M | ¥ 1.11B | ¥ 1.09B | ¥ 1.01B | ¥ 908.67M | |
| ¥ 363.98M | ¥ 534.37M | ¥ 534.58M | ¥ 476.71M | ¥ 425.59M | |
| ¥ -5.07M | ¥ -717.25K | ¥ -1.90M | ¥ -4.93M | ¥ -4.36M | |
| ¥ 358.92M | ¥ 533.65M | ¥ 532.69M | ¥ 471.77M | ¥ 421.23M | |
| ¥ 289.89M | ¥ 470.02M | ¥ 496.51M | ¥ 411.06M | ¥ 348.55M | |
| Per Share Metrics | |||||
| Basic EPS | ¥ 0.42 | ¥ 0.69 | ¥ 0.72 | ¥ 0.62 | ¥ 0.56 |
| Diluted EPS | ¥ 0.42 | ¥ 0.69 | ¥ 0.72 | ¥ 0.61 | ¥ 0.56 |
| Weighted Average Shares Outstanding | 689.51M | 682.41M | 689.60M | 663.22M | 622.41M |
| Weighted Average Shares Outstanding (Diluted) | 691.62M | 682.41M | 691.95M | 674.09M | 622.41M |
Currency in CNY
